文献速递腹部技术与安全US

新型叠层微血管成像用于增强慢性肝病纤维化检测的效用

The Utility of a Novel Stacked Microvascular Imaging for Enhanced Detection of Fibrosis in Chronic Liver Diseases.
PubMed 文献 · Ultrasound Med Biol · 2024-04-07

研究开发了叠层微血管成像(SMVI),通过累积3-5秒高清晰度彩色图像连续显示肝内血管纤维化改变,并制定0-6分SMVI评分。纳入469例明确诊断的慢性肝病患者,按弹性成像定义的纤维化分期分组,比较SMVI评分与常规B型肝形态评分及实验室纤维化标志物的诊断性能。结果显示SMVI在早期纤维化(F0-1High)中检测微血管狭窄达92%,多因素logistic回归显示SMVI评分区分F0-1Low与F0-1High的准确性最高。

要点

  • SMVI通过累积3-5秒高清晰度彩色图像实现肝内血管不间断显示,便于检测纤维化改变。
  • SMVI评分量化狭窄、管径不规则和扭曲三项血管改变,各0-2级,总分0-6分。
  • SMVI在F0-1High期检测微血管狭窄的检出率为92%。

核心结论

  • SMVI可增强慢性肝病肝纤维化的血管成像,尤其在早期阶段,SMVI评分可作为确定慢性肝病纤维化分期的首要工具。

研究设计与样本

  • 研究纳入469例明确诊断的慢性肝病患者,按弹性成像定义的肝纤维化分期分为F0-1Low、F0-1High、F2、F3和F4组,比较SMVI评分与常规B型肝形态评分及多种实验室纤维化标志物的诊断性能。

关键影像表现/征象

  • SMVI通过累积3-5秒倾斜扫描模式的高清晰度彩色图像,实现肝内血管不间断显示,便于检测纤维化改变。
  • SMVI在F0-1High期检测微血管狭窄的检出率为92%。
  • 管径不规则和扭曲的检出率在早期阶段较低,但在晚期阶段成比例增加。

诊断标准与关键数值

  • SMVI评分量化三项肝纤维化血管改变:狭窄、管径不规则和扭曲,各0-2级,总分0-6分。

临床应用与阅片要点

  • SMVI评分在区分F0-1Low与F0-1High病例方面,较B型评分或实验室检测评分最准确。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Ultrasonographic imaging plays a primary role to detect fibrotic changes in patients with chronic liver disease (CLD). To enhance detectability of fibrosis in its early stage, we developed a novel stacked microvascular imaging (SMVI) that enables continuous visualization of fibrotic changes in intrahepatic vessels.

METHODS: SMVI was produced by accumulating 3-5 seconds of high-definition color images in tilted-scan mode. An SMVI score was devised by quantitating three hallmark vascular changes in liver fibrosis in 0-2 grades (total 0-6): narrowing, caliber irregularity, and tortuosity. To evaluate the clinical utility of the SMVI score, 469 well-defined CLD patients were enrolled and subgrouped by the stage of liver fibrosis defined based on elastography: F0-1Low, F0-1High, F2, F3, and F4. The diagnostic performance of the SMVI score was compared to conventional B-mode liver morphology score and various laboratory test markers of fibrosis.

RESULTS: Unlike conventional microvascular imaging that relies on a single image, SMVI enabled an undisrupted view of intrahepatic vessels for easy detection of fibrotic changes. SMVI detected microvascular narrowing in 92% at stage F0-1High. While detection rates for caliber irregularity and tortuosity were low at early stages but increased proportionately in advanced stages. Multiple logistic regression analysis revealed that SMVI score was most accurate in distinguishing F0-1Low from F0-1High cases compared to B-mode or laboratory test scores.

CONCLUSION: SMVI provides enhanced vascular images of liver fibrosis in CLD, especially in its early stage. The SMVI score can be used as a primary tool for determining fibrotic stages in CLD.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Miura D, Suenaga H, Ichihara K, et al. The Utility of a Novel Stacked Microvascular Imaging for Enhanced Detection of Fibrosis in Chronic Liver Diseases. Ultrasound Med Biol. 2024. PMID: 38584023. doi:10.1016/j.ultrasmedbio.2024.03.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。